Results 171 to 180 of about 426,190 (338)

Family history of haematological malignancy and prognosis across non‐Hodgkin lymphoma subtypes

open access: yesBritish Journal of Haematology, EarlyView.
Multivariable‐adjusted associations between family history of haematological malignancy (FHHM) and survival outcomes by non‐Hodgkin lymphoma subtype [OS (A), EFS (B), LSS (C) and failure to achieve EFS at 24 months (D)]. Subtype‐specific analyses showed that FHHM was associated with significantly inferior EFS in MCL and inferior LSS in FL.
George A. Cholack   +16 more
wiley   +1 more source

Mantle flow below the central and greater Alpine region: insights from SKS anisotropy analysis at AlpArray and permanent stations

open access: gold, 2020
Laura Petrescu   +4 more
openalex   +1 more source

Identifying the pre‐Odra river system with hydroacoustic and seismic reflection imagery offshore Rügen Island, southern Baltic Sea

open access: yesBoreas, EarlyView.
Understanding the course and dynamics of ancient river systems, such as the pre‐Odra, provides valuable insights into the post‐glacial evolution of landscapes and riverine processes. The northwest‐trending pre‐Odra was an important drainage system of the European mainland into the Baltic Basin during and after the Scandinavian Ice Sheet retreat ...
Maryse C. Schmidt   +4 more
wiley   +1 more source

Upper mantle low-velocity layer tied to volatile-charged carbonate melts. [PDF]

open access: yesSci Adv
Huang Y   +6 more
europepmc   +1 more source

Bruton tyrosine kinase (Btk) in neutrophils is indispensable for initiating and maintaining skin inflammation in a model of pemphigoid diseases

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Bruton tyrosine kinase (Btk) is essential for B cell function. Its role in myeloid cells is less understood. Greater insights into Btk significance in myeloid cells are needed to evaluate its potential as a therapeutic target during the effector phase of antibody‐induced autoimmune diseases, where inhibiting autoantibody ...
Henning Olbrich   +7 more
wiley   +1 more source

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy